18 февраля 2002 00:00 |
Surgery for aortic and pulmonary valve disease
AORTIC VALVE DISEASE
The most common causes of aortic valve disease are rheumatic fever, endocarditis, congenital abnormalities, and collagen vascular disorders. The physiological sequelae and symptomatic profile of aortic stenosis, aortic insufficiency, or combined stenotic and insufficient lesions are remarkably similar, at least initially. This chapter, however, will deal only with the acquired variety as seen in adults and will not deal with hypertrophic cardiomyopathies, which may also mimic aortic valve disease.
Aortic stenosis is characterized by a long, latent period, when the patient is asymptomatic, even in the presence of a clinically detectable, systolic murmur in the aortic area. The late onset of symptoms is due to the great ability of the heart to compensate for increasing pressure gradients across the aortic valve, principally through the development of myocardial hypertrophy. Hypertrophy can progress for many years before the ratio of muscle fibre volume to capillaries exceeds that required for oxidative metabolism. Even at this point, myocardial cells develop subtle biochemical changes, such as shifts in their lactate dehydrogenase isozyme profiles, that allow the cell to contract under relatively anaerobic conditions for many years. The development of hypertrophy is also associated with unremitting fibrosis that, although insidious, eventually results in a stiff,
Critical aortic stenosis is associated with a high incidence of sudden death, and surgery should be undertaken even in individuals with minimal or no symptoms. A minimally symptomatic patient who does not have a critical aortic valve area, should be monitored carefully for the onset or progression of symptoms, hypertrophy, or left ventricular strain by electrocardiography. Heart size should be monitored by chest radiography, and left ventricular wall thickness and contractility
Unlike aortic stenosis, chronic aortic insufficiency can be tolerated for many years. In contrast to the 100 per cent 3−year mortality rate of aortic stenosis, aortic insufficiency carries a 50 per cent mortality rate over a 10−year period (Fig. 2) 1807. Like aortic stenosis, chronic aortic insufficiency also leads to left ventricular hypertrophy; however, the volume overload also produces distension and progressive ventricular dilatation. The insidious dilatation and fibre stretching produces the progressive, irreversible loss of myocardial fibres that is characteristic of aortic insufficiency. When fibre loss has reached a critical point, surgical intervention will do little to alter the patient's clinical state. It is therefore important to perform aortic valve replacement before the onset of clinically apparent congestive heart failure, manifest by pulmonary oedema. A change in exercise tolerance or the onset of shortness of breath are important premonitory signs. In addition to accurate history taking and careful physical examination, the timing of surgery is also facilitated by monitoring changes in cardiac silhouette by chest radiography and following changes in chamber
Acute aortic insufficiency such as that produced by endocarditis or collagen vascular disorders (i.e. isolated detached cusp) carries a much higher early mortality rate as there are no compensatory adaptive measures in place. Accordingly, while patients with acute endocarditis should ideally receive a full 6−week course of antibiotics, this is often impossible. The timing of aortic valve replacement secondary to acute aortic insufficiency depends primarily upon clinical symptoms. The onset of orthopnoea or shortness of breath will invariably proceed within hours to acute pulmonary oedema, and should be considered as an important signal for the need for surgery. Electrocardiographic changes of volume overload
Valve repair has not yet gained general acceptance as a form of surgical treatment for aortic valve disease: in most cases, present management calls for valve replacement. There are many prosthetic devices available, each of which has its own advantages and disadvantages. In general, the use of tissue valves is restricted to older patients (≥70 years) due to their higher incidence of failure in younger patients, and to patients who cannot receive anticoagulants.
Heavy calcification is invariably associated with aortic stenosis rather than aortic insufficiency. A calcified annulus may obliterate landmarks which are necessary for careful debridement, such as the aortic leaflet of the mitral valve and the atrioventricular node area. Pieces of calcium may fall into the coronary orifices or become trapped in trabeculae, with subsequent cerebral or systemic embolization. Perivalvular leaks secondary to inadequate annular decalcification or iatrogenic perforations of the root of the aorta from excessive decalcification may occur.
This is often associated with acute endocarditis. Abscesses can burrow into the myocardium, with destruction of the annulus and valve leaflets. It is often necessary to place Teflon backed sutures from outside the aorta into the aortic lumen and through the valve sewing ring, or to use the medial wall of the pulmonary artery to buttress the suture line and ensure a competent valve–annulus alignment.
Narrow aortic root
This is invariably associated with aortic stenosis or mixed
PULMONARY VALVE SURGERY
With the advent of balloon valvulotomy for pulmonic stenosis, surgery for pulmonary valve disease is now reserved almost exclusively for the treatment of obstructive pulmonary artery abnormalities or the secondary pulmonic insufficiency that results from surgery upon the right ventricular outflow tract. Most patients with right ventricular outflow tract obstruction are children with conditions such as hypoplastic right ventricular outflow tract, absent pulmonary valve syndrome (invariably associated with annular stenosis), and double outlet right ventricle. Symptoms normally include dyspnoea, fatigue, congestive heart failure, cyanosis caused by shunting through atrial septal defects or a patent foramen ovale and, in infants, poor feeding. Patients rarely become symptomatic when the peak outflow tract gradient is less than 50 mmHg.
Occasionally patients may be referred for pulmonic surgery because of residual infundibular gradients following balloon valvuloplasty. Approximately 20 per cent of patients with pulmonic stenosis have secondary infundibular obstruction. In one study, five of 13 infundibular gradients disappeared following valvuloplasty in 62 patients; five patients developed new infundibular gradients. Patients that had systemic
For all intents and purposes, pulmonary insufficiency is not caused by rheumatic fever, endocarditis, or collagen vascular disorders. It is iatrogenic, and follows transannular repair of tetralogy of Fallot, or repair of other surgical disorders involving the right ventricular outflow tract. It may be serious or inconsequential but affected patients should be monitored carefully for the onset of right ventricular deterioration. Major pulmonary regurgitation is often associated with peripheral pulmonary artery stenosis. The most important symptom of a deteriorating right ventricle is fatigue, and the key signs are a murmur of tricuspid insufficiency and its associated systemic physical findings. Important radiological and angiographic signs include progressive cardiomegaly, a regurgitant fraction above 30 per cent and a transannular patch to descending aorta ratio of at least 2.5. Patients with these signs should undergo surgery promptly. In a study performed by Ilbawi et al., 42 patients with radiographic findings of pulmonary insufficiency following tetralogy of Fallot repair underwent pulmonic valve replacement. At subsequent catheterization of 18 patients, right ventricular function became normal in 83 per cent of those that had undergone surgery within 2 years of tetralogy repair, while right ventricular function remained abnormal in all 12 patients who underwent valve replacement more than 2 years following tetralogy repair. Although we recommend that pulmonary competency should be restored early after the documentation of significant pulmonary insufficiency, a review of the literature indicates that satisfactory results are obtainable for many years following the surgical creation of pulmonary insufficiency.
Surgery for pulmonary insufficiency
Surgical treatment of pulmonary insufficiency falls into three major categories: valve replacement with a mechanical or biological valve prosthesis, conduit replacement with aortic or pulmonary artery homografts
Despite the well known rapid degradation of biological valves in the aortic and mitral positions in children, they appear to provide excellent
Replacement of the pulmonary valve with homografts
Fresh or cryopreserved aortic or pulmonic homografts are more versatile, provide good functional results, are technically easy to use, and have a low incidence of calcification. Due to the shortage of homograft material, both the aorta and pulmonary arteries should be harvested from donor hearts. The advantage of the pulmonary homograft
Single cusp angioplasty attempts to create some degree of pulmonary competence when the pulmonary annulus has been divided. One approach is to insert a transannular patch consisting of an aortic homograft with one cusp preserved or bovine or porcine pericardial patches with a monocusp. A second approach is to fold the inferior margin of the incised native pulmonary artery into the outflow tract and then reconstruct the pulmonary artery with pericardium. The portion of pulmonary artery wall in the lumen acts as a valve cusp. Both procedures seem to help in the postoperative period by decreasing pulmonic regurgitation, but their
Agarwal KC, Edwards WD, Feldt RH, Danielson GK, Puga FJ, McGoon DC. Pathogenesis of nonobstructive fibrous peels
Agarwal KC, Edwards WD, Feldt RH, Danielson GK, Puga FJ, McGoon DC. Clinicopathological correlates of obstructed
Bonow RO, et al. Timing of operation for chronic aortic regurgitation. Am J Cardiol 1982; 50: 325–36.
Bove EL, Kavey
Cowgill LD, Campbell DN, Kelminson L, Clarke DR. Repair of pulmonary valve insufficiency using an autologous monocusp. Ann Thoracic Surg 1986; 42: 587–9.
Finck SJ, Puga FJ, Danielson GK. Pulmonary valve insertion during reoperation for tetralogy of Fallot. Ann Thoracic Surg 1988; 45: 610–3.
Fleming WH, Sarafian LB, Moulton AL, Robinson LA, Kugler JD. Valve replacement in the right side of the heart in children:
Geha AS, Hammond GL, Laks H, Stansel HC, Glenn WWL. Factors affecting performance and thromboembolism after porcine xenograft cardiac valve replacement. J Thoracic Cardiovasc Surg 1982; 83: 377–84.
Hammond GL, Geha AS, Kopf GS, Hashim SW: Biological versus mechanical valves. J Thoracic Cardiovasc Surg 1987; 93: 182–98.
Ilbawi MN, et al. Factors that exaggerate the deleterious effects of pulmonary insufficiency on the right ventricle after tetralogy repair. J Thoracic Cardiovasc Surg 1987; 93: 36–44.
Ilbawi MN, et al. Experience with St. Jude medical valve prosthesis in children. J Thoracic Cardiovasc Surg 1987; 93: 73–9.
Kay PH, Ross DN. fifteen years' experience with the aortic homograft: The conduit of choice for right ventricular outflow tract reconstruction. Ann Thoracic Surg 1985; 40: 360–4.
Konno S, et al. A new method for prosthetic valve replacement in congenital aortic stenosis associated with hypoplasia of the aortic valve ring. Bull Heart Inst Jpn 1974; 15: 1–17.
McGoon DC, Danielson GK, Puga FJ, Ritter DG, Mair DD, Ilstrup DM. Late results after extracardiac conduit repair for congenital cardiac defects. Am J Cardiol 1982; 49: 1741–9.
Miyamura H, Kanazawa H, Hayashi J, Eguchi S. Thrombosed St. Jude medical valve prosthesis in the right side of the heart in patients with tetralogy of Fallot. J Thoracic Cardiovasc Surg 1987; 94: 148–156.
Osbakken M, Bove AA, Span JF. left ventricular function in chronic aortic regurgitation with reference
Raasten H, Koncz J. Aortoventriculoplasty. A new technique for treatment of left ventricular outflow obstruction. J Thoracic Cardiovasc Surg 1976; 71: 920.
Rao PS. Indications for balloon pulmonary valvuloplasty. Am Heart J 1988; 16: 1661–2.
Sievers HH, et al.
Thayar MK, Rao PS. Significance of infundibular obstruction following balloon valvuloplasty for valvar pulmonic stenosis. Am Heart J 1989; 118: 99–103.
22 февраля 2002 | 00:02Артериопатии
18 февраля 2002 | 00:02Современное состояние проблемы лечения острого коронарного синдрома
Современное состояние проблемы лечения острого коронарного синдрома
18 февраля 2002 | 00:02Прямые ингибиторы тромбина в терапии острых коронарных синдромов
Прямые ингибиторы тромбина в терапии острых коронарных синдромов
18 февраля 2002 | 00:02Minimally Invasive Valve Surgery
Minimally Invasive Valve Surgery
15 февраля 2002 | 00:02ВОДНО-СОЛЕВОЙ ГОМЕОСТАЗ И ЕГО КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ
ВОДНО-СОЛЕВОЙ ГОМЕОСТАЗ И ЕГО КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ